Graduated compression stockings are universally
|
|
- Cathleen Hunt
- 5 years ago
- Views:
Transcription
1 Efficacy of Graduated Compression Stockings for an Additional 3 Weeks after Sclerotherapy Treatment of Reticular and Telangiectatic Leg Veins PAVAN K. NOOTHETI, MD, KRISTIAN M. CADAG, BS, ANGELA MAGPANTAY, MPH, MT (ASCP), AND MITCHEL P. GOLDMAN, MD BACKGROUND Sclerotherapy with post-treatment graduated compression remains the criterion standard for treating lower leg telangiectatic, reticular, and varicose veins, but the optimal duration for that postsclerotherapy compression is unknown. OBJECTIVE To determine whether 3 weeks of additional graduated compression with Class I compression stockings (20 30 mmhg) improves efficacy when used immediately after 1 week of Class II (30 40 mmhg) graduated compression stockings. METHODS Twenty-nine patients with reticular or telangiectatic leg veins were treated with sclerotherapy; one leg was assigned to wear Class II compression stocking for 1 week only, and the contralateral leg was assigned an additional 3 weeks of Class I graduated compression stocking. RESULTS AND CONCLUSIONS Postsclerotherapy pigmentation and bruising was significantly less with the addition of 3 weeks of Class I graduated compression stockings. This study was supported by a grant from Sigvaris and Medi USA, who supplied the compression stockings used in this study. Dr. Goldman is a consultant and receives honoraria from Bioniche/Angiodynamics. Graduated compression stockings are universally recommended for surgical and nonsurgical treatment of varicose veins. Whereas graduated compression is thought to be particularly essential after sclerotherapy of large varicose veins, it has not been universally adopted after sclerotherapy treatment of telangiectasia. For varicose veins, less thrombus formation results in a lower incidence of postsclerosis pigmentation. 1 4 Immediate postsclerotherapy compression is thought to result in direct apposition of treated vein walls, which produces more effective sclerosis by limiting thrombus formation. In addition, limitation of thrombosis and inflammation secondary to phlebitis may minimize telangiectatic matting. 5,6 The degree and length of time for compression after sclerotherapy treatment is debatable. A trial of highversus low-compression stockings (40 vs 15 mmhg at the ankle) after varicose vein surgery demonstrated equal efficacy in controlling bruising and thrombophlebitis. 7 This same study concluded that, after varicose vein surgery, Class I (20 30 mmhg) compression stockings provided adequate support, but that after sclerotherapy, Class II (30 40 mmhg) compression stockings were necessary. Nevertheless, in terms of controlling objective and subjective parameters of venous insufficiency, no difference was found between Class I and Class II compression. 8 One of the authors (MPG) previously evaluated postsclerotherapy compression with Class II graduated compression stockings in 37 women with telangiectasia in a multicenter study. A decrease in hyperpigmentation from 40.5% to 28.5% was demonstrated. Ankle and calf edema were also decreased. 9 The same author next evaluated postsclerotherapy Class I graduated compression All authors are affiliated with Dermatology/Cosmetic Laser Associates of La Jolla, Inc., La Jolla, California & 2008 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc. ISSN: Dermatol Surg 2009;35:53 58 DOI: /j x 53
2 SCLEROTHERAPY TREATMENT OF LEG VEINS TABLE 1. Sclerosing Solutions Used for Leg Veins Based on Diameter Veins o1mm in diameter Veins 1 3 mm in diameter Veins 3 6 mm in diameter 2% glycerin mixed 2:1 with 1% lidocaine with epinephrine 0.25% sotradecol foam (1 ml solution with 4 ml of air) 0.5% sotradecol foam (1 ml solution with 4 ml of air) stockings in 40 patients with similar telangiectatic patterns. 10 These patients were randomly assigned to compression durations of 0 days, 3 days, 1 week, and 3 weeks. The three compression groups showed significantly greater improvement at 6 weeks (p =.004). There was a strong correlation between the length of time compression was applied and degree of improvement at 6, 12, and 24 weeks. The patients treated with compression for 3 days and 1 week had more improvement than the control patients, and the patients treated for 3 weeks with continuous graduated compression had the most improvement. When improvement after sclerotherapy was followed to 12 and 24 weeks, the benefits of compression were even more evident. Patients in the 3-week compression group had the greatest improvement, followed by the 1-week group, with similarly decreasing rates of improvement at 12 Patient Quality of Life Questionnaire 1- What is your current level of pain? Do you have any leg swelling? A)Yes 3- Do you have any bruising? A) Yes 4- Do you have any leg ulcerations (bleeding)? A) Yes 5- Do you have any discoloration, and if so, what grade? A) None B) Mild C) Moderate D) Severe 6- Do you have any pigmentation? a. No, none b. Mild c. Moderate d. Severe 7- Using a percentage score, please describe the amount of vein clearance that you believe you have gained since your procedure. A) 0% B) 10% C) 20% D) 30% E) 40% F) 50% G) 60% H) 70% I) 80% J) 90% K) 100% 8- Do you feel a sensation of heaviness? A) Yes Figure 1. Patient quality-of-life questionnaire. 54 DERMATOLOGIC SURGERY
3 NOOTHETI ET AL (p =.02) and 24 (p =.006), weeks of follow-up in the 3-day and control groups. There were no statistically significant differences between the four groups in the incidence of bruising, telangiectatic matting, edema, or ulceration, although trends of lessening were noted with increasing times of compression. There was a statistically significant difference, however, between the groups regarding hyperpigmentation. The 1-week and 3-week compression groups experienced the least amount of hyperpigmentation. These two studies demonstrate the benefits of postsclerotherapy treatment of leg telangiectasia with Class I and Class II graduated compression stockings. Compression for 1 to 3 weeks appears to be most beneficial. This was also confirmed in a study on the use of compression for varicose veins. 11 Materials and Methods Thirty-three patients with reticular and telangiectatic leg veins in a similar pattern, size, and extent on both legs were treated with sclerotherapy. The sclerosing solutions used were sodium tetradecyl sulfate (STS) (Angiodynamics, Buffalo, NY) and glycerin 72% mixed 2:1 with 1% lidocaine with epinephrine (University Compounding Pharmacy, San Diego, CA) as previously described. 12 The treatment regimen is outlined in Table 1. A subjective quality-of-life questionnaire was administered before treatment and at 7- to 8-week follow-up to all patients (Figure 1). After sclerotherapy treatment, patients wore Class II 30- to Physician Questionnaire Figure 2. Physician questionnaire. 1- Three (3) independent physician observers will assess pre- and post-treatment photographs to determine overall disappearance of veins by the following scale (1-5): 1 = Worse than before treatment 2 = No change 3 = Minor disappearance 4 = Moderate disappearance 5 = Complete disappearance 2- Three (3) independent physician observers will assess pre- and post-treatment photographs to determine degree of pigmentation on a scale of (1-4): 1 = no pigmentation 2 = mild pigmentation 3 = moderate pigmentation 4 = severe pigmentation 3- Three (3) independent physician observers will assess pre- and post-treatment photographs to determine degree of superficial thrombophlebitis on a scale of (1-4): 1 = no evidence of phlebitis 2 = mild phlebitis 3 = moderate phlebitis 4 = severe phlebitis 4-4. Three (3) independent physician observers will assess pre- and post-treatment photographs to determine degree of ankle/pedal edema on a scale of (1-4): 1 = no edema 2 = mild edema 3 = moderate edema 4 = severe edema 35:1:JANUARY
4 SCLEROTHERAPY TREATMENT OF LEG VEINS Sclerotherapy Study (Average Means based on Photograding) Randomized Group Non-Randomized Group 0.00 Overall Disappearance of Veins Degree of Pigmentation Degree of Superficial Thrombosis Figure 3. Sclerotherapy study (average means based on photograding). 40-mmHg graduated compression stockings for 1 week, 24 hours a day (Sigvaris 860 series, thigh high, Sigvaris Inc., Peachtree City, GA, or Mediven Plus, Medi USA, Whitsett, NC). Patients legs were then randomized so that one leg had no stocking, and the other leg had a Class I 20- to 30-mmHg graduated compression stocking (Sigvaris 860 series, thigh high, or Mediven Plus) while ambulatory for an additional 3 weeks. Two physicians (PKN and MPG) assessed photographs in a blinded manner taken before treatment and 7 to 8 weeks post-treatment. Overall disappearance of leg veins, degree of pigmentation, and degree of superficial thrombophlebitis was graded on a 1 to 4 scale (Figures 2 and 3). Interrater reliability was calculated using the Spearman rank coefficient (n = 22, alpha = 2-tailed). We found that the measure of agreement in the rating estimates of our two physicians (calculated rho = 0.40) was stable and consistent (po.05). Results Of the 33 subjects initially enrolled, 29 completed participation. The four subjects who dropped out of the study did not return for follow-up at all of the time periods. There did not appear to be any adverse effects in the four subjects who dropped out of the study. Statistical analysis showed a significant difference in the degree of post-treatment pigmentation between the 1-week and 4-week compression groups (p =.01), but no difference was observed in the overall disappearance of leg veins (p =.52) or degree of superficial thrombophlebitis (p =.32) (Figure 3). The Mann-Whitney test was used for statistical analysis of photograding, with an alpha = 0.05 (two-tailed) with 95% confidence limits. Immediately after treatment and during each followup visit, subjects were questioned regarding current level of pain, swelling, bruising, ulceration, discoloration, pigmentation, vein clearance percentage, and sensation of heaviness. At the final visit, 45% and 5% of the 4-week compression group reported the presence of swelling and bruising, respectively, compared with the 1-week compression group, who developed swelling in 25% and bruising in 15%. Conclusion There was a statistically significant difference in the degree of post-treatment pigmentation between 1 56 DERMATOLOGIC SURGERY
5 NOOTHETI ET AL and 4 weeks of graduated compression stocking wear. No statistical significant difference was evident in the overall disappearance of veins and degree of superficial thrombophlebitis. There was less pigmentation and telangiectatic matting in patients who wore Class I graduated compression stockings for an additional 3 weeks versus wearing Class II graduated compression stockings for 1 week after sclerotherapy treatment. Patients who wore the Class I graduated stockings for an additional 3 weeks reported feelings of leg comfort while wearing the stockings during full motion and at rest. Limitations to our study include small sample size. Although the debate will continue with regard to the length of time compression is needed after sclerotherapy, we have demonstrated that an additional 3 weeks of postsclerotherapy compression can hasten the disappearance of post-treatment pigmentation or bruising, thereby improving overall appearance of the legs faster. References 1. Goldman MP. Postsclerotherapy hyperpigmentation. Treatment with a flashlamp-excited pulsed dye laser. J Dermatol Surg Oncol 1992;18: Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Dermatol 1987;17: Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 1987;13: Duffy D. Techniques of Small Vessel Sclerotherapy. In: Goldman M, Weiss R, Bergan J., editors. Varicose Veins and Telangiectasia: Diagnosis and Treatment. 2nd ed. St. Louis: Quality Medical Publishing; 1999: Ouvry PA, Davy A. The sclerotherapy of telangiectasia. Phlebologie 1982;35: Davis L., Duffy DM. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: A retrospective analysis. J Dermatol Surg Oncol 1990;16: Shouler PJ, Runchman PC. Varicose veins: optimum compression after surgery and sclerotherapy. Ann R Coll Surg Engl 1989;71: Spence RK, Cahall E. Inelastic versus elastic leg compression in chronic venous insufficiency: a comparison of limb size and venous hemodynamics. J Vasc Surg 1996;24: Goldman MP, Beaudoing D, Marley W, et al. Compression in the treatment of leg telangiectasia: a preliminary report. J Dermatol Surg Oncol 1990;16: Weiss RA, Sadick NS, Goldman MP, Weiss MA. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999;25: Tazelar DJ, Neumann HA, De Roos KP. Long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 1999;25: Goldman MP, Bergan JB, Guex JJ, editors. Sclerotherapy Treatment of Varicose and Telangiectatic Leg Veins. 4th ed. London: Mosby/Elsevier; Address correspondence and reprint requests to: Mitchel P. Goldman, MD, Dermatology/Cosmetic Laser Associates of La Jolla, Inc., 7630 Fay Ave., La Jolla, CA 92037, or mgoldman@spa-md.com COMMENTARY This small and carefully crafted study deserves analysis at three levels: proof of concept, practicality or utility value, and issues that have not been directly addressed. PROOF OF CONCEPT It is becoming increasingly apparent that by increasing the duration and degree of compression, a linear decline is noted in certain types of postsclerotherapy complications. In this report, the authors note a statistically significant difference in post-treatment pigmentation. Bruising and telangiectatic matting may also be reduced with more-aggressive compression protocols. 35:1:JANUARY
6 SCLEROTHERAPY TREATMENT OF LEG VEINS UTILITY VALUE Implicit in this article is the notion that all patients undergoing sclerotherapy for vessels large and small would benefit from one week of around-the-clock Class II hosiery followed by another three weeks of around-the-clock Class I hosiery. Whether we should recommend patients to routinely employ this expensive, difficult-to-put-on, and uncomfortable hosiery to avoid minor temporary complications is problematic. When treating telangiectasia or very small reticular veins, it might be worthwhile to discuss the benefits and drawbacks of compression therapy and leave the decision up to the patient. ISSUES THAT WERE NOT DIRECTLY ADDRESSED Class II hosiery, which is ordinarily used to treat severe varicosities, may impair calf muscle and cutaneous blood flow in recumbent patients. 1 For patients with pre-existing circulatory problems, diabetes mellitus, and certain kinds of podiatric problems, the risk of vascular compromise may outweigh the benefits. Although the authors seem convinced that aggressive compression protocols may be a panacea for a wide range of complications, personal experience suggests that pigmentation, matting, bruising, and swelling can occur on a highly variable individual and not completely predictable basis; 2 4 no matter what treatment protocols are employed. CONCLUSION Although some of the benefits ascribed to compression may be artifacts related to individual patient variability, a study of this sort underscores the increasingly appreciated benefits of postsclerotherapy compression. DAVID DUFFY, MD Torrance, CA Dr. Duffy has no conflicts to disclose. References 1. Goldman MP, Bergan JJ, Guex JJ. SclerotherapyFTreatment of Varicose and Telangiectatic Leg Veins. 4th ed. London: Mosby; Duffy D. Techniques of small vessel sclerotherapy. In: Goldman M, Weiss R, Bergan J., editors. Varicose Veins and Telangiectasia: Diagnosis and Treatment. 2nd ed. St. Louis: Quality Medical Publishing; p Davis LT, Duffy DM. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: A retrospective analysis. J Dermatol Surg Oncol 1990;16: Alam M, Tri H, Nguyen DD. Procedures in cosmetic dermatology; treatment of leg veins. In: Sclerotherapy. St. Louis: Elsevier Inc.; Ch 5, p DERMATOLOGIC SURGERY
Clinical comparison of sodium tetradecyl sulfate 0.25% versus polidocanol 0.75% in sclerotherapy of lower extremity telangiectasia
ORIGINAL ARTICLE Clinical comparison of sodium tetradecyl sulfate 0.25% versus polidocanol 0.75% in sclerotherapy of lower extremity telangiectasia Wafaa M Ramadan, MD, Khaled H El-Hoshy, MD, Dalia M Shaaban,
More informationEvaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy
Evaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy Rizwan H. Bukhari, MD, Joann M. Lohr, MD, Douglas S. Paget, MD, Andrew T. Hearn, MD, and Robert D. Cranley, MD,
More informationDisclosure. Lowell Kabnick, M.D., FACS, FACPh. I disclose the following financial relationship(s):
Disclosure Lowell Kabnick, M.D., FACS, FACPh I disclose the following financial relationship(s): Research Grant: BTG; Ownership Interest: AngioDynamics, Vascular Insights; Consultant/Advisory Board: AngioDynamics,
More informationVaricose Veins What Are They? Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018
Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018 Sclerotherapy for Venous Disease: Overview 1 in 5 Americans Approximately 25% of women have some type of lower
More information[Kreussler Studies] FDA. multicenter GCP. controlled. randomized. prospective. blinded SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS
[Kreussler Studies] SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS FDA randomized controlled GCP blinded prospective multicenter [Sclerotherapy of Varices] Healthy legs with microfoam Chemische
More informationChronic Venous Insufficiency Compression and Beyond
Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial
More informationDate: A. Venous Health History Form. Patient please complete questions Primary Care Physician:
E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your
More informationPriorities Forum Statement
Priorities Forum Statement Number 9 Subject Varicose Vein Surgery Date of decision September 2014 Date refreshed March 2017 Date of review September 2018 Relevant OPCS codes: L841-46, L848-49, L851-53,
More informationDate: A. Venous Health History Form. Patient please complete questions Primary Care Physician:
E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your
More informationA short review of diagnosis and compression therapy of chronic venous. insufficiency, Clinical picture and diagnosis A B S T R A C T WORDS
A short review of diagnosis and compression therapy of chronic venous insufficiency N. Kecelj Leskovec, M. D. Pavlovi}, and T. Lunder A B S T R A C T Introduction: Chronic venous insufficiency (CVI) is
More informationAging hands are characterized by prominent
Foam Sclerotherapy for Reticular Veins of the Dorsal Hands: A Retrospective Review Anne Marie Tremaine, MD,* Daniel P. Friedmann, MD, and Mitchel P. Goldman, MD BACKGROUND Despite being the gold standard
More informationVisual Sclerotherapy. 1:24-1:36 Now 10 minutes flying along. Nick Morrison, MD, FACPh, FACS President, International Union of Phlebology
1:24-1:36 Now 10 minutes flying along Visual Sclerotherapy Nick Morrison, MD, FACPh, FACS President, International Union of Phlebology Sedona, Arizona Canyon de Chelly, Airzona Disclosures Educational
More informationLast literature review version 19.3: Fri Sep 30 00:00:00 GMT 2011 This topic last updated: Thu Sep 30 00:00:00 GMT 2010 (More)
19.3 Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins Authors Deborah L Greenberg, MD, FACP Sherry Scovell, MD, FACS Section Editors John F Eidt, MD Joseph L Mills, Sr,
More informationAdditional Information S-55
Additional Information S-55 Network providers are encouraged, but not required to participate in the on-line American Venous Forum Registry (AVR) - The First National Registry for the Treatment of Varicose
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL This policy applies to the following lines of business: MedStar Employee (Select) MedStar CareFirst PPO MedStar Health considers the treatment of Varicose
More informationCompression after sclerotherapy and endovenous ablations, the Italian point of view
Compression after sclerotherapy and endovenous ablations, the Italian point of view Fabrizio Mariani Siena (Italy) General Secretary "Multidisciplinary Joint Committee in Phlebology" - UEMS (EU) General
More informationLove your legs again Varicose Veins
Love your legs again Varicose Veins Veins are the vessels that return blood to the heart once it has circulated through the body (as opposed to arteries, which carry oxygen-rich blood from the heart to
More informationPOLIDOCANOL VS STS FOR SPIDER VEINS. Steven E. Zimmet, MD RPVI RVT FACPh
POLIDOCANOL VS STS FOR SPIDER VEINS Steven E. Zimmet, MD RPVI RVT FACPh Disclosures/COI No COI Off-label use Lipid bilayer with membrane proteins Lipid bilayers are the basic structures that make up cell
More informationPatient Information. Venous Insufficiency and Varicose Veins
Patient Information Venous Insufficiency and Varicose Veins What is a Varicose Vein? Gitter Vein Institute-revised 3/8/2016 2 Frequently Asked Questions What is the difference between varicose and spider
More informationSclerotherapy Complications and Contra-Indications
Sclerotherapy Complications and Contra-Indications Dr Paul Thibault Phlebologist Newcastle NSW Sclerotherapy Complications and Contraindications Not everything that needs to be known can be taught Sclerotherapy
More informationClassification for elastic tubes, medical socks and soft bandaging?
Classification for elastic tubes, medical socks and soft bandaging? Dr. Martin Abel Head of Medical & Regulatory Affairs, Lohmann & Rauscher GmbH & Co KG Copenhagen, 17.05.2013 1 Standard Bandages in UK
More informationFoam Sclerotherapy of the Saphenous Veins: Randomised Controlled Trial with or without Compression
Eur J Vasc Endovasc Surg (21) 39, 5e57 Foam Sclerotherapy of the Saphenous Veins: Randomised Controlled Trial with or without Compression C.M. Hamel-Desnos a, *, B.J. Guias b, P.R. Desnos c, A. Mesgard
More informationPROF S.R.SUBRAMMANIYAN INSTITUTE OF VASCULAR SURGERY MADRAS MEDICAL COLLEGE
PROF S.R.SUBRAMMANIYAN INSTITUTE OF VASCULAR SURGERY MADRAS MEDICAL COLLEGE VARICOSE VEINS OF SUPERFICIAL VENOUS SYSTEM OF LOWER LIMBS A SYMPTOM NOT A DISEASE INITIAL,MILD CASES and severe cases with contraindication
More informationThis information is intended as a general guide only. Please ask if you have any questions relating to this information.
Foam Sclerotherapy (Varicose vein injections) Vascular Surgery This information is intended as a general guide only. Please ask if you have any questions relating to this information. Varicose Veins Veins
More informationAppendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES. CP Direct Vision Sclerotherapy Clinical procedure
Appendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES CP Direct Vision Sclerotherapy Clinical procedure 1 PURPOSE This procedure summarises the actions required
More informationVenous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.
Venous Insufficiency Ulcers Patient Assessment: Superficial varicosities Evidence of healed ulcers Dermatitis Normal ABI Edema Eczematous skin changes 1. Scaling 2. Pruritus 3. Erythema 4. Vesicles Lipodermatosclerosis
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES TREATMENT OF VARICOSE VEINS OF THE LOWER EXTREMITIES STAB PHLEBECTOMY AND SCLEROTHERAPY TREATMENT The primary purpose of this document is to assist providers enrolled in
More informationHow varicose veins occur
Varicose veins are a very common problem, generally appearing as twisting, bulging rope-like cords on the legs, anywhere from groin to ankle. Spider veins are smaller, flatter, red or purple veins closer
More informationlipodermatosclerosis standards of medical practitioners and the quality of patient care related to the treatment of venous disorders.
Chattanooga s premiere VEIN CENTER Update on Venous Insufficiency, Varicose and Spider Veins 2016 Vincent W. Gardner, MD, FACS, RPVI Fellow, American College of Surgeons Board Certified, American Board
More informationWhich place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany
Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany Liquid Foam or GSV, foam / liquid sclerosant n diameter[mm] Follow up effectivity Hamel Desnos 2003
More informationRADIOFREQUENCY ABLATION. Professor M Baguneid MB ChB MD FRCS
RADIOFREQUENCY ABLATION This minimally invasive treatment involves closing the faulty veins using a keyhole approach thereby avoiding the larger cuts and avoiding stripping of the veins. Professor M Baguneid
More informationOccasional pain or other discomfort (ie, not restricting regular daily activity)
Revised Venous Clinical Severity Score Pain : 0 Mild: 1 or other discomfort (ie, aching, heaviness, fatigue, soreness, burning) Occasional pain or other discomfort (ie, not restricting regular daily activity)
More informationA Novel Approach for the Treatment of Spider Veins
Cosmetic Medicine A Novel Approach for the Treatment of Spider Veins Mirsad Mujadzic, MD; Edmond F. Ritter, MD; and Kenna S. Given, MD, FACS Aesthetic Surgery Journal 2015, Vol 35(7) NP221 NP229 2015 The
More informationExpanding Your Vein Business Terri Morrison, RN, B.S., CEO Morrison Vein Institute Scottsdale/Tempe Arizona
Expanding Your Vein Business Terri Morrison, RN, B.S., CEO Morrison Vein Institute Scottsdale/Tempe Arizona March 8, 2011 Varicose Vi Vein Market Approximately 40% of the US population has venous disease;
More informationpressure of compression stockings matters (clinical importance of pressure)
Classification of Compression Stockings ICC Meeting, Copenhagen, May 17, 2013. pressure of compression stockings matters (clinical importance of pressure) Giovanni Mosti; Lucca, Italy disclosure no conflict
More informationPHLEBOLOGY. Venous Insufficiency. Presentation Use Information
Disclosure of Conflict of Interest THE BASICS OF VENOUS INSUFFICIENCY: What You Should Know. An Introductory Lecture Donald Ives, MD, RVT, RPVI Board Certified Family Physician Diplomate of the American
More informationTessari L. Nouvelle technique d'obtention de la sclero-mousse. Phlebologie 2000;53:129.
Appendix 1 to Microsclerotherapy Standard AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES CP - Microsclerotherapy - Clinical procedure 1 PURPOSE This procedure summarises the actions required to
More informationDr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology
Dr Paul Thibault Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Prescribing Effective Compression and PTS Dr Paul Thibault Phlebologist, Newcastle,
More informationEpidemiology: Prevalence
Epidemiology: Prevalence More than 30 million Americans suffer from varicose veins or a more serious form of venous disease called Chronic Venous Insufficiency (CVI). 1 Of the over 30 million Americans
More informationLaser Treatment of Leg Veins
Laser Treatment of Leg Veins Updated: Sep 17, 2015 Author: Mitchel P Goldman, MD; Chief Editor: Dirk M Elston, MD more... Overview Background Public interest in laser and light treatment of leg veins is
More informationOriginal Article Intervention
Original Article Intervention http://dx.doi.org/10.3348/kjr.2014.15.4.481 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2014;15(4):481-487 Fluoroscopy-Guided Endovenous Sclerotherapy Using a Microcatheter
More informationLatmedical, LLC is the exclusive Caribbean distributor
No-Varix Graduated Compression Hosiery is manufactured by TEXPON S.A., the only Latin- American company certified with the norm ISO 9001:00 with scope of manufacture of graduate compression hosiery for
More informationFind From Varicose Veins. VenaSeal
Find Relief From Varicose Veins VenaSeal Closure System Understand Varicose veins may be a sign of something more severe venous reflux disease. Your doctor can help you understand if you have this condition.
More informationCommunity Pharmacy Foundation Grant. Quantitative Test of Lower Extremity Circulation Eric Driggers, PharmD
Community Pharmacy Foundation Grant Quantitative Test of Lower Extremity Circulation Eric Driggers, PharmD Introduction: Greenhaw Pharmacy is an independently owned pharmacy located in Hillsboro, Kansas.
More informationFIND RELIEF FROM VARICOSE VEINS. VenaSeal Closure System
FIND RELIEF FROM VARICOSE VEINS VenaSeal Closure System UNDERSTAND Varicose veins may be a sign of something more severe venous reflux disease Your doctor can help you understand if you have this condition.
More informationVeClose trial Cyanoacylate closure vs. RF ablation 36-month results
VeClose trial Cyanoacylate closure vs. RF ablation 36-month results LINC 2018, Leipzig 31 st Jan 2018 Tobias Hirsch, Halle, Germany www.gefaessmedizin-hirsch.de Disclosure Tobias Hirsch I have the following
More informationCOMMISSIONING POLICY
Ref No. 1a7.5 COMMISSIONING POLICY Surgery for venous disease of the leg (Varicosities of the Long Saphenous Vein) April 2011 CONTENTS Section Page Summary 2 1. Background 2 2. Criteria for eligibility
More informationManagement of Post-Thrombotic Syndrome
Management of Post-Thrombotic Syndrome Thanainit Chotanaphuti Phramongkutklao College of Medicine Bangkok, Thailand President of CAOS Asia President of Thai Hip & Knee Society President of ASEAN Arthroplasty
More informationDisclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.
Management of Venous Disease: an evidence based approach Disclosures Ed Boyle, MD Andrew Jones, MD Dr. Ed Boyle and Dr. Andrew Jones disclose Grants/research support: Medtronic, BTG International, Clearflow,
More informationVein & Body Specialists at The Bellevue Hospital Spider Vein and Varicose Vein Treatments
1 Vein & Body Specialists at The Bellevue Hospital Spider Vein and Varicose Vein Treatments What are spider veins? Spider veins are dilated, small blood vessels that have a red or bluish color. They appear
More informationVaricose Veins. These are abnormal veins in the legs that appear as unsightly or cause other problems.
Varicose Veins What are varicose veins? These are abnormal veins in the legs that appear as unsightly or cause other problems. They develop due to abnormal valve function that allows the blood to travel
More informationVaricose Vein Surgery
What are varicose veins? Varicose veins are enlarged and twisted veins in your leg. Varicose veins are common, affecting up to 3 in 10 people. Varicose veins tend to run in families and are made worse
More informationOHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009
OHTAC Recommendation Endovascular Laser Treatment for Varicose Veins Presented to the Ontario Health Technology Advisory Committee in November 2009 April 2010 Issue Background The Ontario Health Technology
More informationRecurrent Varicose Veins
PHLEBOLOGY Recurrent Varicose Veins Part 2: Injection of Incompetent Perforating Veins Using Ultrasound Guidance PAUL KENNETH THIBAULT, MBBS WARREN ANTHONY LEWIS, DMU Treatment options following duplex
More informationSCLEROTHERAPY. Cosmetic purposes to improve the appearance of varicose and spider veins
SCLEROTHERAPY Sclerotherapy effectively treats varicose and spider veins. It's often considered the treatment of choice for small varicose veins. Sclerotherapy involves injecting a solution directly into
More informationFeatures compression after open and endovascular operation in vascular malformation
Features compression after open and endovascular operation in vascular malformation Sapelkin Sergey Institute of Surgery named A.V. Vishnevsky, Moscow, Russia 21.10.2017 CIRC Meeting, Grassau AV-malformations:
More informationchronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis, Klippel- Trenaunay syndrome DVT CVD
Online publication August 27, 2009 chronic venous disorders: CVD CEAP 4 CEAP CVD J Jpn Coll Angiol, 2009, 49: 201 205 chronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis,
More informationHow does compression really work?
How does compression really work? Felizitas Pannier Private Practice Phlebology & Dermatology, Bonn, Germany Many thanks to Hugo Partsch, Horst Gerlach and Hans-Jürgen Thomä for some of the pictures Compression
More informationTraining Outline. History of medi. Circulation in the body. Medical Conditions. Athletic Conditions. Compression in Sports. Compression for recovery
Compression 101 1 Training Outline History of medi Circulation in the body Medical Conditions Athletic Conditions Compression in Sports Compression for recovery Tips 2 History of medi medi began in the
More informationVaricose veins. Information for patients Sheffield Vascular Institute
Varicose veins Information for patients Sheffield Vascular Institute You have been diagnosed as having varicose veins. This leaflet explains more about varicose veins and answers some of the most frequently
More informationLASERS: CAN THEY TREAT SPIDER VEINS? Steven E. Zimmet, MD
LASERS: CAN THEY TREAT SPIDER VEINS? Steven E. Zimmet, MD No conflicts of interest DISCLOSURES YES! WHY USE LASERS FOR LEG VEINS? Patient s Perception Less Painful Newer technology Must be better Needle
More informationClinical/Duplex Evaluation of Varicose Veins: Who to Treat?
Clinical/Duplex Evaluation of Varicose Veins: Who to Treat? Sanjoy Kundu MD, FASA, FCIRSE, FSIR The Vein Institute of Toronto Scarborough Vascular Group Scarborough Vascular Ultrasound Scarborough Vascular
More informationJOURNAL OF WOUND CARE. VOLUME 8. NUMBER 9. October A comparison of sub-bandage pressures produced with two multi-layer bandaging systems
JOURNAL OF WOUND CARE VOLUME 8. NUMBER 9. October 1999 A comparison of sub-bandage pressures produced with two multi-layer bandaging systems A.D. Taylor, MSc, RGN, SCM, DN, Clinical Nurse Specialist, Salford
More informationPATIENT STUDY INFORMATION LEAFLET
PATIENT STUDY INFORMATION LEAFLET BOOKLET 1 You are invited to take part in this research study. Before you decide, it is important for you to understand why the research is being done and what it will
More informationIntroduction AIM OF THE STUDY
A double blind, randomized study evaluating the influence of semi-synthetic diosmin, and a purified, micronized flavonoid fraction (diosmin and hesperidin), on symptoms of chronic venous insufficiency
More informationHigh Level Overview: Venous Anatomy of Lower Extremities. Anatomy of a Vein 5/11/2015. Barbara Deusterman, RN
High Level Overview: Venous Anatomy of Lower Extremities Barbara Deusterman, RN What does this anatomy lecture have to do with visually guided sclerotherapy (VGS)? May 11, 2015 2 Anatomy of a Vein Almeida,
More informationDr Peter Chapman-Smith
Dr Peter Chapman-Smith Phlebologist NZ Stem Cell Treatment Centre, Whangarei 12:00-12:30 Healing Those Heartsink Leg Ulcers Healing Those Heartsink Leg Ulcers Practice Nurses Presentation GPCME Christchurch
More informationVaricose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment.
Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment. Approximately 1 in 5 adult Americans suffer from superficial
More informationPATIENT EDUCATION HANDBOOK
PATIENT EDUCATION HANDBOOK Welcome from Our Founder and CEO 1 What is Venous Insufficiency 2 What Factors Can Cause Varicose Veins? 2 Our Procedures 3 Pre- and Post-Operative Instructions 4 Sclerotherapy
More informationAppendix 7c Varicose Veins Task and Finish Group meeting, 3 May 2018 Notes of key discussion points
Appendix 7c Varicose Veins Task and Finish Group meeting, 3 May 2018 Notes of key discussion points Task and Finish Group members Attendees: Stella Vig Vascular Consultant Surgeon & Clinical SWL Director
More informationRandomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein
Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein Raghu Kolluri, MD, Director Vascular Medicine OhioHealth Riverside Methodist Hospital
More informationSincerely, Michael R. Probstfeld, M.D., FACS Southern Arizona Laser & Vein Institute A MESSAGE ABOUT OUR PATIENT HISTORY FORM
A MESSAGE ABOUT OUR PATIENT HISTORY FORM. Dear Patients, Thank you in advance for taking the time to accurately complete our SALVI patient questionnaire. This valuable tool helps us to help you. Due to
More informationTreatment of telangiectasias by. foam sclerotherapy? under. ultrasound guidance. How to ensure the success of. 10 rules to respect
How to ensure the success of foam sclerotherapy? under 10 rules to respect Treatment of telangiectasias by ultrasound guidance Claudine Claudine Hamel-Desnos MD Hôpital Privé Caen- Saint France Martin
More informationMedicare C/D Medical Coverage Policy
Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: February 15, 2017 Next Review: February, 2019 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins
More informationPerforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015
Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Anatomy of Perforating veins Cadaveric studies 1 have shown >60 vein perforating veins from superficial to deep Normal
More information2013 Vol. 24 No
2013 Vol. 24 No. 3 333 1 2 2013 24 3 317-322 1 2 1 2 2012 8 6 57 333 Table 1 Compression bandages available in Japan Classification Feature Name Distributor Short stretch non-cohesive Comprilan Terumo
More informationAll you need to know about. Varicose Veins. & its treatments. in 10 mins
All you need to know about Varicose Veins & its treatments in 10 mins Contents Symptoms and Causes...04 Risk Factors...05 Relief: The Top Five Tips...06 Compression Stockings or Bandages...08 New Surgery
More informationMEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies
MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationSadie Ahanchi, MD Sentara Vascular Specialists April 27,2018. Debate 1: Why Is Tumescent-Based Therapy The Gold Standard?
Sadie Ahanchi, MD Sentara Vascular Specialists April 27,2018 Debate 1: Why Is Tumescent-Based Therapy The Gold Standard? Tumescent based venous therapy: Fight! Introduction Tumescent anesthesia Administration
More informationMEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies
MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationSclerotherapy: treatment for thread veins on the legs
Sclerotherapy: treatment for thread veins on the legs What causes thread veins and varicose veins? 50% of the population will develop problems with their leg veins during their life. In most cases there
More informationMEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies
MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
More informationTreatment of Chronic Venous Ulcers Using New Four Layers Compressive Bandage Dressing
ORIGINAL ARTICLE J Nepal Med Assoc 215;53(199):156-61 CC S BY NC OPEN ACCESS Treatment of Chronic Venous Ulcers Using New Four Layers Compressive Bandage Dressing Kaushal K Tiwari, 1 Krishna G Shrestha,
More informationEfficacy of Velcro Band Devices in Venous and. Mixed Arterio-Venous Patients
Efficacy of Velcro Band Devices in Venous and Mixed Arterio-Venous Patients T. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery Martha-Maria Hospital
More informationCriteria For Medicare Members. Kaiser Foundation Health Plan of Washington
Clinical Review Criteria Treatment of Varicose Veins Radiofrequency Catheter Closure Sclerotherapy Surgical Stripping Trivex System for Outpatient Varicose Vein Surgery VenaSeal Closure System VNUS Closure
More informationDetermine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient.
Patient Assessment :Venous History, Examination and Introduction to Doppler and PPG Dr Louis Loizou The 11 th Annual Scientific Meeting and Workshops of the Australasian College of Phlebology Tuesday 18
More informationVaricose Vein Cyanoacrylate Glue treatment
The South West s premier independent healthcare and cosmetic clinic Varicose Vein Cyanoacrylate Glue treatment Varicose veins are a sign of underlying venous insufficiency and affect 20 30% of adults.
More informationPrevalence. Definition. Chronic Venous Insufficiency. Overview of Chronic Venous Insufficiency
Overview of Chronic Venous Insufficiency Steven M. Dean, DO, FACP, RPVI Vascular Medicine Specialist Assistant Professor of Internal Medicine Department of Cardiovascular Medicine The Ohio State University
More informationV I U R E V I E W. T h e O f f i c i a l J o u r n a l o f V e n o u s I n s u f f i c i e n c y U n i v e r s i t y
C o m p l i m e n t s o f S a n j i v L a k h a n p a l, M D, J a i m e M a r q u e z, M D, J e r r i l y n J u t t o n, M D, K e l l y O ' D o n n e l l, M D, R a j i v J h a v e r i, M D, L u i s A.
More informationVein Disease Treatment
MP9241 Covered Service: Yes when meets criteria below Prior Authorization Required: Yes as indicated in 2.0, 3.0, 4.0 and 5.0 Additional Information: None Prevea360 Health Plan Medical Policy: Vein disease
More informationTreatment of Varicose Veins
Treatment of Varicose Veins Policy Number: Original Effective Date: MM.06.016 04/15/2005 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 09/28/2018 Section: Surgery Place(s) of
More informationVarithena 3 rd February 2015
Varithena 3 rd February 2015 Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other forward-looking statements with respect to
More informationTaken into account multidiscilinary aspect of Vascular Compression
The Vascular Center : A model to improve patient care Taken into account multidiscilinary aspect of Vascular Compression F. Vin C. Gardon-Mollard Compression Therapy is an efficient treatment for the management
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate
PACKAGE LEAFLET: INFORMATION FOR THE USER Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate Read all of this leaflet carefully before you start using this medicine. Keep
More informationCurrent Management of Varicose Veins
Current Management of Varicose Veins Michael J. Heidenreich, MD St. Joseph Mercy Hospital Ann Arbor, MI March 23, 2013 Nothing to disclose History Prevalence Anatomy Risk factors Clinical manifestations
More informationThe use of compression stockings for venous disorders in Brazil
The use of compression stockings for venous disorders in Brazil J L Cataldo*, J M Pereira de Godoy and N de Barros Jr *Service of Peripheral Vascular Disease, University of Campinas UNICAMP; Department
More informationTibbs DJ. Varicose veins and related disorders. Oxford: Butterworth-Heinemann; ISBN
1 PURPOSE This procedure summarises the actions required to diagnose venous disease using clinical examination and Duplex/Doppler ultrasound, and to treat superficial venous incompetence using Endovenous
More informationResearch Article Reduction of Pain and Edema of the Legs by Walking Wearing Elastic Stockings
International Vascular Medicine Volume 2015, Article ID 648074, 4 pages http://dx.doi.org/10.1155/2015/648074 Research Article Reduction of Pain and Edema of the Legs by Walking Wearing Elastic Stockings
More informationHealthy Legs For Life! Prevention is better then cure
Healthy Legs For Life! Prevention is better then cure Ellie Lindsay Independent Specialist Practitioner Associate Lecturer, CRICP, London Visiting Fellow, Queensland University of Technology Occurrence
More informationRECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY Paul Kramer, MD, FACC, FSCAI Liberty Cardiovascular Specialists Liberty Regional Heart and Vascular Center DISCLOSURES NONE Venous
More information